Myeloma Center

You are here


Amyloidosis is a rare disease characterized by a buildup of abnormal proteins called amyloids within organs like the heart, kidneys and liver. The Myeloma Center’s Dr. Cara Rosenbaum specializes in the care and treatment of people with amyloidosis and is a long-time partner of the nationwide patient support and advocacy organization, Amyloidosis Support Groups, facilitiated by Muriel Finkel. The amyloidosis support group meeting took place on the Weill Cornell Medicine/NewYork-Presbyterian...
Three-drug combinations have demonstrated benefit both for newly diagnosed myeloma patients who go on to undergo autologous stem cell transplantation, as well as for those who are transplant-ineligible. Often included in these triplet combinations is a proteasome inhibitor. Proteasome is the protein complex responsible for maintaining cell homeostasis by disposing of proteins not useful to the body. Proteasome inhibitors -- which have become a staple of myeloma treatment -- work by impeding...
Renal impairment, a common comorbidity of multiple myeloma, occurs when the body’s kidneys cannot efficiently filter waste products from the blood. Associated with poor survival outcomes, renal impairment can limit treatment options, as well as complicate dosing for people with myeloma.In search of more effective and well-tolerated therapies for myeloma patients with renal impairment, Dr. Ruben Niesvizky and colleagues analyzed the results of the phase III ENDEAVOR study – a comparison of...
Each year, the American Society of Hematology (ASH) Annual Meeting and Exposition convenes over 25,000 clinicians and scientists from around the world to discuss the latest research into the treatment of blood diseases. This year’s 60th Annual ASH Meeting brought exciting advancements with potential to improve care for people with myeloma, amyloidosis and other plasma cell disorders. Here are some research highlights from the meeting.Emerging Treatment Technology: BiTEsAlmost all myeloma cells...
Tour Our New Home
The Weill Cornell Medicine Myeloma Center's new home on 425 E 61st Street features semi-private infusion spaces, a dedicated social worker, and more! Join the Center's Director, Dr. Ruben Niesvizky, and Associate Director, Dr. Adriana Rossi, for a virtual tour. Video of Weill Cornell Medicine Myeloma Center Tour
Drs. Rossi and Monge standing at a podium.
The national Multiple Myeloma Rounds Program was established in 2016 to provide a forum for local healthcare professionals to address specific issues related to the diagnosis and treatment of multiple myeloma patients. At the recent CME-accredited Multiple Myeloma Rounds Program in New York City, several key opinion leaders and subject matter experts were invited to speak about topics related to myeloma patient care and treatment.
Tubes in a bundle.
Dr. Ruben Niesvizky, Weill Cornell Medicine Myeloma Center Director, and Dr. Kenar Jhaveri, nephrologist and Professor of Medicine in the Division of Kidney Diseases and Hypertension at Hofstra and Northwell Health, published an editorial in the Journal of the American Medical Association (JAMA) addressing the role of using a special form of hemodialysis in myeloma patients with kidney damage.
Myeloma Research Updates at the 2017 American Society of Hematology Annual Meeting
Researchers and physicians at the Weill Cornell Medicine and NewYork-Presbyterian Multiple Myeloma Center presented cutting-edge research at this year’s American Society of Hematology (ASH) Annual Meeting and Exposition, an educational gathering of over 25,000 clinicians and scientists from around the world who are working to conquer blood disease.
Lymphoma and Myeloma 2017: An International Congress on Hematologic Malignancies
Since its inception in 2000, the Lymphoma and Myeloma Congress has grown to include attendees from over 40 countries. The Congress is the premier forum on the latest advances in lymphoma, myeloma and related plasma cell disorders. This year, the Congress utilized a dynamic approach that featured clinical controversies, debates, and interesting lectures involving conversations around current treatment regimens as well as promising treatments in the development pipeline.Approximately 1,000...
Nurse Practitioner at Myeloma Center Named Oncology Nurse of the Year
Terry Atkins, Vice President of Marketing and Communications at Extended Stay America gives Karen Pekle, NP the Hotel Keys of Hope 2017 Oncology Nurse of the Year Award Photo courtesy of Extended Stay AmericaKaren Pekle, nurse practitioner at the Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP) Myeloma Center, was awarded the 2017 Oncology Nurse of the Year Award in Charleston, South Carolina by the Hotel Keys of Hope Program – a joint initiative between Extended Stay America and the...

Weill Cornell Medicine Myeloma Center 425 East 61st St
8th Floor
New York, NY 10065 Phone: (646) 962-6500 Fax: (212) 746-8961